Bone Marrow Stem Cell release Study has shown an increase of 25-30%, 2-4 million circulating stem cells
Safe Daily Stem Cell Support: The New PARADIGM in Health and Wellness
AFA ( Aphanizomenon flos-aquae) has been on the market for about 30 years and those that have consumed it have reported a wide variety of health benefits.
L selectin is an adhesion molecule, it's role is to maintain the Stem cell in the bone marrow.
Blocking L-selectin increases the probability that a stem cell gets released from the bone marrow.
With scientific research a 5:1 proprietary concentrate of AFA concentrates the L-selectin ligand.
Feeding 1 gram of this AFA concentrate to individuals was shown to increase the number of circulating stem cells by 25-30%, adding approximately 2-4 million new stem cell to the bloodstream. This was confirmed with a double blind crossover placebo controlled study. This is a safe physiologic increase that is well within normal range of the body and thus presents no risk to the body.
Thus AFA concentrate is the first Natural stem cell enhancer. This puts a new paradigm of supporting health and wellness in place. Consuming the AFA concentrate supports the release of stem cells from the bone marrow, which supports the natural renewal system. This may very well be the best strategy to assist the body in maintaining optimal health.
In theory, since bone marrow stem cells (BMSC) have the ability of becoming virtually any cells of the body, supporting bone marrow stem cell release has the potential of supporting ALL aspect s of human health.
BMSC have been shown to support the health of:
Hope this helps, for more information see http://vgstem12.stemtechbiz.com
All the best,
Victor Genchi, DDS, MD
Yes Caffeine is the treatment of choice for apnea of prematurity. Very low birth weight infants (VLBW) were ramdomly assigned to receive caffeine therapy or placebo. Those who received caffeine therapy had lower rates of cerebral palsy and cognitive delay at 18 and 21 months of age. However at 60 months neonatal caffeine therapy was no longer assciated with a significantly improved rate of survival without disability in children with very low birth weights. This study at age 5 reports results of detailed assesment of motor function, cognition, behavior, general health, hearing and vision after the study paticipants had reached the age of 5.
In Summary the neonatal caffeine therapy in VLBW infants (Preterm) showed the benefits on the rate of survival without disability at 18 months were attenuated during child development. The rates of coognitve impaiment were lower at 5 years than at 18 months, suggesting cognitive delay during the second year of life may not be a lasting outcome after very preterm birth.
JAMA, january 18, 2012--Vol 307, no.3
Symptomatic venous thromboembolism (VTE) after total knee replacement (TPKA) and after total or partial hip arthroplasty (TPHA) are propposed patient safty indicators.
In conclusion, approximatly 1 in every 100 patients undergoing TPKA and 1 in every 200 patients undergoing TPHA developes symtomatic VTE ( DVT or Pulmonary embolus) proir to hospital discharge. These values could be used as a benchmark to evaluate patient safty indicators derived from routinly collected data
JAMA JANUARY 18, 2012.
Today no one can deny the possibility of adequate nutrition and the prolonged maintainance of health and vigor on a VEGITARIAN lifestyle.
As a practicing Internal medicine physician, the trends that patients have chosen indicate the desire for Natural healthcare options is at the top of their list.